DENTSPLY SIRONA Inc. (XRAY) vs Zenas BioPharma, Inc. (ZBIO)

A side-by-side comparison of DENTSPLY SIRONA Inc. and Zenas BioPharma, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — XRAY vs ZBIO

growth of $100 · dividends reinvested · last 2y
XRAY -64.1% (-40.1%/yr)ZBIO +54.9% (+24.4%/yr)ZBIO compounded faster over this window
50100150200250Start $10020252026$36$155
XRAY ZBIO

XRAY vs ZBIO: by the numbers

  • •XRAY is the larger company ($1.71B vs $1.70B market cap).
  • •Both run net losses; XRAY's is the smaller (-14.99% vs -48438.40% net margin).
  • •XRAY pays a dividend (3.74% yield), while ZBIO has no payments in the available dividend history.

Metrics side by side

Valuation

MetricXRAYZBIO
Forward P/E5.59N/A
P/S ratio0.471700.81
P/B ratio1.266.88
EV / EBITDA4.43N/A
FCF yield8.38%N/A

Profitability

MetricXRAYZBIO
Gross margin49.52%100.00%
Operating margin11.69%-2113.85%
Net margin-14.99%-48438.40%
ROE-40.41%-196.03%
ROIC10.03%-74.69%

Dividends

MetricXRAYZBIO
Dividend yield3.74%N/A

Growth (annualized)

MetricXRAYZBIO
Revenue CAGR (5Y)1.96%N/A
FCF CAGR (5Y)-25.74%N/A
Total return CAGR (5Y)-30.27%N/A

Frequently asked

Does XRAY or ZBIO pay a bigger dividend?
XRAY pays a dividend (3.74% yield), while ZBIO has no payments in the available dividend history.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.